Dengue: defining protective versus pathologic immunity
- PMID: 15057297
- PMCID: PMC379334
- DOI: 10.1172/JCI21512
Dengue: defining protective versus pathologic immunity
Abstract
Dengue is an expanding public health problem, and an effective vaccine remains elusive. This review discusses how the significant influence of sequential infection with different dengue virus serotypes on the severity of disease can be viewed in terms of beneficial and detrimental effects of heterologous immunity. A more complete understanding of these effects is likely to be critical for predicting optimal vaccine-induced immune responses.
Figures
References
-
- Rigau-Perez JG, et al. Dengue and dengue haemorrhagic fever. Lancet. 1998;352:971–977. - PubMed
-
- Pinheiro FP, Corber SJ. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. World Health Stat. Q. 1997;50:161–169. - PubMed
-
- Rigau-Perez JG. The early use of break-bone fever (Quebranta huesos, 1771) and dengue (1801) in Spanish. Am. J. Trop. Med. Hyg. 1998;59:272–274. - PubMed
-
- Kalayanarooj S, et al. Early clinical and laboratory indicators of acute dengue illness. J. Infect. Dis. 1997;176:313–321. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
